Global Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Global Health Limited has informed the BSE that the meeting of the Board of Directors of the Company is scheduled to be held on 03/11/2026, inter alia, to consider and approve Unaudited Financial Results for the Quarter & Half Year ended September 30, 2026.

Date: October 22, 2026 Ref:- GHL/2026-27/EXCH/65 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Bandra Kurla Mumbai - 400 001 Complex, Bandra (E), Mumbai - 400 051 Scrip Code: 543654 Symbol: MEDANTA Sub: Intimation for Board Meeting under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dear Sir(s), We would like to inform that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, November 03, 2026, inter alia, to consider and approve the Unaudited Financial Results of the Company for the Second Quarter and Half Year ended September 30, 2026. Further, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code for prevention of Insider Trading, the Trading Window of the Company is already closed from October 01, 2026 and will re-open after 48 hours from the declaration of above said results. We request you to take the above on record. Thanking You, For Global Health Limited Rahul Ranjan Company Secretary & Compliance Officer M. No. A17035 Regd. Office: E-18, Defence Colony, New Delhi 110024, Ph No.011- 44114411 www.medanta.org, info@medanta.org, CIN: L85110DL2004PLC128319